World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
121
Citations
86429
World Ranking
3532
National Ranking
98

Overview

Philip J. Barter is affiliated with the University of New South Wales in Australia and has produced research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their scholarly work spans subfields including Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Physiology, and Cardiology and Cardiovascular Medicine.

Their research topics reflect a focus on Diabetes, Cardiovascular Risks, and Lipoproteins; Lipoproteins and Cardiovascular Health; Antiplatelet Therapy and Cardiovascular Diseases; Body Composition Measurement Techniques; Physical Activity and Health; Obesity and Health Practices; and Fatty Acid Research and Health.

Philip J. Barter's recent publications include the following papers:

  • Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity, 2020, Nature Reviews Endocrinology
  • Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk, 2020, JAMA
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials, 2022, The Lancet
  • Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis, 2024, The Lancet Diabetes & Endocrinology
  • Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease, 2021, European Heart Journal

Frequent co-authors collaborating with Barter include John J.P. Kastelein, Wolfgang Köenig, Paul M. Ridker, Colin Baigent, and David Preiss, each contributing to several joint publications.

The scientist has published regularly in venues such as Lipids in Health and Disease, Nature Reviews Endocrinology, JAMA, The Lancet, and The Lancet Diabetes & Endocrinology.

Best Publications

  • Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

    A. Tonkin;P. Alyward;D. Colquhoun;P. Glasziou

  • Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

    John C. LaRosa;Scott M Grundy;David D. Waters;Charles Shear

  • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

    A Keech;R J Simes;P Barter;J Best

  • Effects of Torcetrapib in Patients at High Risk for Coronary Events

    Philip J. Barter;Mark Caulfield;Mats Eriksson;Scott M Grundy

  • New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

    Josée Dupuis;Josée Dupuis;Claudia Langenberg;Inga Prokopenko;Richa Saxena;Richa Saxena

  • Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

    Gregory G. Schwartz;Anders G. Olsson;Markus Abt;Christie M. Ballantyne

  • New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (vol 42, pg 105, 2010)

    J Dupuis;C Langenberg;I Prokopenko;R Saxena

  • HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

    Philip Barter;Antonio M. Gotto;John C. LaRosa;Jaman Maroni

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis

    David Preiss;Sreenivasa Rao Kondapally Seshasai;Paul Welsh;Sabina A. Murphy

  • A genome-wide association search for type 2 diabetes genes in African Americans.

    N D Palmer;C W McDonough;P J Hicks;B H Roh

  • Antiinflammatory Properties of HDL

    Philip J. Barter;Stephen Nicholls;Kerry Anne Rye;G. M. Anantharamaiah

  • Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

    Stephen J. Nicholls;Christie M. Ballantyne;Philip J. Barter;M. John Chapman

  • Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity

    Robert Ross;Ian J. Neeland;Shizuya Yamashita;Iris Shai

  • Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis

    Philip J. Barter;H. Bryan Brewer;M. John Chapman;Charles H. Hennekens

  • High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules

    Gillian W. Cockerill;Kerry-Anne Rye;Jennifer R. Gamble;Mathew Alexander Vadas

  • International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries.

    Beverley Balkau;John E. Deanfield;Jean Pierre Després;Jean Pierre Bassand

  • Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement

    Ian J. Neeland;Robert Ross;Jean Pierre Després;Yuji Matsuzawa

  • Erratum: New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk (Nature Genetics (2010) 42 (105-116))

    Josée Dupuis;Claudia Langenberg;Inga Prokopenko;Richa Saxena

  • Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

    Nicholls Sj;Ballantyne Cm;Barter Pj;Chapman Mj

  • Intensive Lipid Lowering With Atorvastatin in Patients With Stable Coronary Disease

    J.C. LaRosa;S.M. Grundy;D.D. Waters

Frequent Co-Authors

Kerry-Anne Rye
Kerry-Anne Rye University of New South Wales
Stephen J. Nicholls
Stephen J. Nicholls Monash University
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Anthony C. Keech
Anthony C. Keech University of Sydney
Christie M. Ballantyne
Christie M. Ballantyne Baylor College of Medicine
Scott M. Grundy
Scott M. Grundy The University of Texas Southwestern Medical Center
David D. Waters
David D. Waters University of California, San Francisco
David S. Celermajer
David S. Celermajer Royal Prince Alfred Hospital
Marja-Riitta Taskinen
Marja-Riitta Taskinen University of Helsinki
Dawn M. Waterworth
Dawn M. Waterworth Johnson & Johnson (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA doesn’t always mean following the traditional path of becoming a physician. There are several flexible, rewarding, and growing healthcare careers available through online study—ideal for those who need to balance work, family, and education. For example, earning a nursing degree online can open doors to roles in hospitals, clinics, and community health settings, often with lower tuition costs and flexible scheduling.

For nurses looking to advance, online doctoral programs are more accessible than ever. The cheapest dnp online program options let you reach the highest level of clinical expertise without the burden of excessive student debt. If you are already a registered nurse (RN), the average cost of rn to bsn programs can be a key factor as you consider moving your qualifications to the next level and expanding your career opportunities.

Even those without previous nursing experience can enter fast-growing advanced practice fields. Direct entry nurse practitioner programs for non-nurses online allow ambitious students from other backgrounds to transition into high-demand healthcare roles. Exploring these alternative online pathways can provide a flexible, affordable route to rewarding medical careers.

Best Scientists Citing Philip J. Barter

Trending Scientists